CRBU
Price
$0.84
Change
+$0.07 (+9.09%)
Updated
Apr 29, 04:36 PM (EDT)
Capitalization
71.77M
14 days until earnings call
FATE
Price
$1.17
Change
-$0.08 (-6.40%)
Updated
Apr 29, 04:42 PM (EDT)
Capitalization
143.25M
One day until earnings call
Ad is loading...

CRBU vs FATE

Header iconCRBU vs FATE Comparison
Open Charts CRBU vs FATEBanner chart's image
Caribou Biosciences
Price$0.84
Change+$0.07 (+9.09%)
Volume$799
Capitalization71.77M
Fate Therapeutics
Price$1.17
Change-$0.08 (-6.40%)
Volume$587
Capitalization143.25M
CRBU vs FATE Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. FATE commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and FATE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (CRBU: $0.77 vs. FATE: $1.25)
Brand notoriety: CRBU and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 346% vs. FATE: 48%
Market capitalization -- CRBU: $71.77M vs. FATE: $143.25M
CRBU [@Biotechnology] is valued at $71.77M. FATE’s [@Biotechnology] market capitalization is $143.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, FATE is a better buy in the long-term than CRBU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 5 TA indicator(s) are bullish while FATE’s TA Score has 5 bullish TA indicator(s).

  • CRBU’s TA Score: 5 bullish, 3 bearish.
  • FATE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than FATE.

Price Growth

CRBU (@Biotechnology) experienced а -2.97% price change this week, while FATE (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was -2.03%, and the average quarterly price growth was -10.94%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2025.

FATE is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($143M) has a higher market cap than CRBU($71.8M). FATE YTD gains are higher at: -24.242 vs. CRBU (-51.465). CRBU has higher annual earnings (EBITDA): -162.69M vs. FATE (-176.58M). FATE has more cash in the bank: 279M vs. CRBU (210M). CRBU has less debt than FATE: CRBU (26.5M) vs FATE (85.3M). FATE has higher revenues than CRBU: FATE (13.6M) vs CRBU (9.99M).
CRBUFATECRBU / FATE
Capitalization71.8M143M50%
EBITDA-162.69M-176.58M92%
Gain YTD-51.465-24.242212%
P/E RatioN/AN/A-
Revenue9.99M13.6M73%
Total Cash210M279M75%
Total Debt26.5M85.3M31%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUFATE
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CCCC. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-0.30%
CCCC - CRBU
55%
Loosely correlated
+5.19%
CRSP - CRBU
53%
Loosely correlated
-1.02%
FATE - CRBU
52%
Loosely correlated
-2.34%
NKTX - CRBU
50%
Loosely correlated
-4.74%
BEAM - CRBU
50%
Loosely correlated
+1.43%
More

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-2.34%
ALLO - FATE
56%
Loosely correlated
+1.29%
NTLA - FATE
53%
Loosely correlated
+2.05%
CRBU - FATE
51%
Loosely correlated
-0.30%
CRSP - FATE
51%
Loosely correlated
-1.02%
CCCC - FATE
49%
Loosely correlated
+5.19%
More